Search results
ALKBH5-mediated m6A modification of circFOXP1 promotes gastric cancer progression by regulating SOX4...
Nature· 4 days agoA study found that circFOXP1 was highly expressed in gastric cancer (GC) and demonstrated that ALKBH5-mediated m6A modification of circFOXP1 promoted GC progression by regulating SOX4 expression and sponging miR-338-3p.
Why is Brown Fat 'Good Fat' for Metabolism? | HHMI
Howard Hughes Medical Institute· 2 days agoLong seen as a villain in metabolic diseases such as diabetes, fat can play the hero too. A study by molecular biologist Shingo Kajimura and his...
Lizard-inspired building design could save lives
Nature· 3 days agoHear the biggest stories from the world of science | 15 May 2024
UC San Diego study finds plant virus may slow the progression of cancer
KSWB articles via Yahoo News· 3 days agoThe team looked at how the plant virus stimulated an immune response in mice with metastatic tumors....
Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung...
Nature· 4 days agoLung adenocarcinoma (LUAD) is one of the most prevalent types of cancer. Ubiquitination is crucial in modulating cell proliferation and aerobic glycolysis in cancer. The frequency of TP53 mutations ...
Plant virus treatment shows promise in fighting me | Newswise
Newswise· 5 days agoAn experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego ...
2 IU professors named among 7 unsung heroes. Learn about their contributions.
The Herald-Times via Yahoo News· 5 days agoTwo Indiana University professors have been named among seven "unsung Jewish American Heroes” thanks...
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
FOX 23 News Albany· 5 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Skipping Axillary Lymph Node Dissection in Breast Cancer?
Medscape· 4 days agoAxillary recurrence was rare among patients who skipped standard axillary lymph node dissection...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoNuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 PR Newswire CAMBRIDGE, Mass., May 16, 2024 CAMBRIDGE, Mass., May 16, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on